Oncology

Division Grants

Grant and Contract AwardsAnnual Direct

Adams, D

Phase II Study of Rapamycin for Complicated Vascular Anomalies
R01 FD 00371209/25/09-07/31/13$248,540

Chow, L

Micro-RNA Expression in Pediatric High-Grade Glioma
-08/01/11-07/31/12$40,000
Micro-RNA Expression in Pediatric High-Grade Glioma
-09/01/11-08/31/13$22,727
Molecular Targeting of High-Grade Astrocytoma
-10/01/11-09/30/15$130,435
Molecular Targeting of Pediatric High-Grade Glioma
07/01/11-06/30/14$110,000

Cripe, T

Neurofibromatosis Preclinical Consortium Center Award
2011-05-00307/01/11-06/30/13$136,364
Phase I Study of HSV1716 in Pediatric Non-CNS Solid Tumors
R01 FD 00371709/01/10-08/31/13$152,618
Acidic Phospholipid-Selective Treatment for Neuroblastoma
R01 CA 15837209/27/11-07/31/13$12,760

Dorris, K

Molecular Epidemiology in Children's Environmental Health
T32 ES01095710/01/10-09/30/12$52,293

Drissi, R

Biology Studies in the First Phase I Trial of a Telomerarase Inhibitor in Children with Refractory or Recurrent Solid Tumors and Lymphomas
08/01/11-07/31/12$40,000

Fouladi, M

Children's Oncology Group Phase I / Pilot Consortium
U10 CA 09745209/16/11-07/31/12$25,662
Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry
01/01/12-12/31/12$155,000
The Pediatric Brain Tumor Consortium
U01 CA 08145704/01/08-03/31/13$93,908
Children's Oncology Group Chair
U10 CA 09854303/01/11-02/29/12$12,500

Hammill, A

Ontogeny and Quantitative Multimodal Skin Imaging of Infantile Hemangiomas
07/01/11-06/30/12$6,500

Perentesis, J

Children's Oncology Group Phase I
U01 CA 09745208/01/07-07/31/11$23,918
Children's Oncology Group Phase I / Pilot Consortium
U01 CA 09745209/01/06-07/31/12$26,124
Cincinnati Children’s Hyundai Scholar in Cancer Survivorship
10/01/11-12/01/12$100,000
Children's Oncology Group Phase I / Pilot Consortium - Per Patient
U01 CA 09745209/01/06-07/31/12$38,058
Children's Oncology Group Chair - Per Patient
U10 CA 09854303/01/11-02/28/12$57,840

Pope, J

Analysis of Antioxidant Polymorphisms in Patients with Down Syndrome and CML
07/01/10-06/30/12$70,804

Wang, P-Y

Virotherapy on Primary Neuroblastoma Cells
07/01/10-06/30/12$41,250

Wells, S

Fanconi Anemia and HPV Transformation
R01 CA 10235709/28/09-08/31/14$191,834
Current Year Direct$1,789,135
Industry Contracts

Fouladi, M

$30,800

Geller, J

$25,000

Weiss, B

$15,574

Absalon, M

$3,332

Cripe, T

$88,250

Wagner, L

$16,178
$1,016
Current Year Direct Receipts$180,150
Funded Collaborative Efforts

Wells, S

Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection
Butsch-Kovacic07/01/11-06/30/163%
Total$1,969,285